NCT00736385View on ClinicalTrials.gov

Metformin for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)

PHASE4TerminatedINTERVENTIONAL

Enrollment

11

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

Fatty Liver

Interventions

DRUG

Glucophage (Metformin)

metformin XR 2000 mg daily for 12 months

DRUG

Placebo

placebo 2000 mg daily for 12 months

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER

NCT00736385 - Metformin for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) | Biotech Hunter | Biotech Hunter